Scholarlink

<i>Background</i> <p>Despite advancements in diagnostics and treatment strategies, infective endocarditis continues to carry a&#xa0;substantial morbidity and mortality risk. In addition, the field of infective endocarditis contains many gaps in evidence, as international guidelines are predominantly based on low-level evidence. To improve infective endocarditis care and survival rates in the Netherlands, adequate evaluation of diagnostics, treatment strategies and outcomes is essential.</p> <i>Methods</i> <p>To address this need, a&#xa0;new infective endocarditis registry has been developed by the multidisciplinary ENDOCOR working group with the aim of facilitating nationwide quality control, improving infective endocarditis patient care, and contributing to the numerous gaps in evidence. To optimize data collection, facilitated by the Netherlands Heart Registration (NHR), a&#xa0;pilot project was launched in January 2023 across three selected hospitals.</p> <i>Results</i> <p>The findings from the first 150 registered patients were presented to highlight the registry’s potential. Following the pilot, many more centres have initiated data collection, demonstrating national engagement and scalability of the initiative.</p> <i>Conclusion</i> <p>This article outlines the purpose of ENDOCOR, presents initial pilot data and illustrates the potential of the new national infective endocarditis registry to enhance patient care and support future research.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

ENDOCOR: a nationwide consortium of endocarditis teams—initiating a registry for infective endocarditis within the Netherlands Heart Registration

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年9月3日

查看全文
  • Annelot J. L. Peijster,
  • Floris J. Heinen,
  • Sabrine Douiyeb,
  • Michelle D. van der Stoel,
  • Jasper L. Selder,
  • Anouk G. W. Watson-de Lepper,
  • Patrick Houthuizen,
  • Matthijs F. L. Meijs,
  • Linda M. Kampschreur,
  • Simon Schalla,
  • Bhanu N. M. Sinha,
  • Annelies L. M. Bakker,
  • Ilse J. E. Kouijzer,
  • Francisca Nijland,
  • C. H. Edwin Boel,
  • Robert K. Riezebos,
  • Mariëlle G. J. Duffels,
  • Jesper Hjortnaes,
  • Robert J. M. Klautz,
  • Nelianne J. Verkaik,
  • Marco C. Post,
  • Steven A. J. Chamuleau,
  • Otto Kamp,
  • Wilco Tanis

摘要

Background

Despite advancements in diagnostics and treatment strategies, infective endocarditis continues to carry a substantial morbidity and mortality risk. In addition, the field of infective endocarditis contains many gaps in evidence, as international guidelines are predominantly based on low-level evidence. To improve infective endocarditis care and survival rates in the Netherlands, adequate evaluation of diagnostics, treatment strategies and outcomes is essential.

Methods

To address this need, a new infective endocarditis registry has been developed by the multidisciplinary ENDOCOR working group with the aim of facilitating nationwide quality control, improving infective endocarditis patient care, and contributing to the numerous gaps in evidence. To optimize data collection, facilitated by the Netherlands Heart Registration (NHR), a pilot project was launched in January 2023 across three selected hospitals.

Results

The findings from the first 150 registered patients were presented to highlight the registry’s potential. Following the pilot, many more centres have initiated data collection, demonstrating national engagement and scalability of the initiative.

Conclusion

This article outlines the purpose of ENDOCOR, presents initial pilot data and illustrates the potential of the new national infective endocarditis registry to enhance patient care and support future research.